| Targeting MDM2 for novel molecular therapy: Beyond oncology W Wang, JJ Qin, M Rajaei, X Li, X Yu, C Hunt, R Zhang Medicinal research reviews 40 (3), 856-880, 2020 | 67 | 2020 |
| A novel inhibitor of MDM2 oncogene blocks metastasis of hepatocellular carcinoma and overcomes chemoresistance W Wang, B Hu, JJ Qin, JW Cheng, X Li, M Rajaei, J Fan, XR Yang, ... Genes & Diseases 6 (4), 419-430, 2019 | 37 | 2019 |
| Association between polymorphisms at promoters of XRCC5 and XRCC6 genes and risk of breast cancer M Rajaei, I Saadat, S Omidvari, M Saadat Medical Oncology 31, 1-4, 2014 | 25 | 2014 |
| Targeted brain tumor therapy by inhibiting the MDM2 oncogene: In vitro and in vivo antitumor activity and mechanism of action SR Punganuru, V Arutla, W Zhao, M Rajaei, H Deokar, R Zhang, ... Cells 9 (7), 1592, 2020 | 15 | 2020 |
| Two birds with one stone: NFAT1-MDM2 dual inhibitors for cancer therapy W Wang, A Zafar, M Rajaei, R Zhang Cells 9 (5), 1176, 2020 | 12 | 2020 |
| Introducing a novel allele for the polymorphism of variable number of tandem repeats in the promoter region of XRCC5 M Rajaei, I Saadat, M Saadat Biochemical and Biophysical Research Communications 427 (3), 503-505, 2012 | 11 | 2012 |
| The novel allele (3R) of the VNTR polymorphism in the XRCC5 promoter region dramatically decreases the gene expression M Rajaei, I Saadat, M Saadat Biochemical and Biophysical Research Communications 430 (2), 640-641, 2013 | 10 | 2013 |
| Clinical response to chemotherapy in locally advanced breast cancer was not associated with several polymorphisms in detoxification enzymes and DNA repair genes M Saadat, M Khalili, M Nasiri, M Rajaei, S Omidvari, I Saadat Biochemical and biophysical research communications 419 (1), 117-119, 2012 | 10 | 2012 |
| High resolution melting analysis for detection of variable number of tandem repeats polymorphism of XRCC5 M Rajaei, I Saadat, M Saadat Biochemical and Biophysical Research Communications 425 (2), 398-400, 2012 | 9 | 2012 |
| Targeting MDM2 for neuroblastoma therapy: in vitro and in vivo anticancer activity and mechanism of action W Wang, X Wang, M Rajaei, JY Youn, A Zafar, H Deokar, JK Buolamwini, ... Cancers 12 (12), 3651, 2020 | 8 | 2020 |
| Association between inbreeding coefficient and susceptibility to HIV-1 infection, a case-control study M Rajaei, M Saadat Germs 3 (4), 122, 2013 | 5 | 2013 |
| AKAP12 Upregulation Associates With PDE8A to Accelerate Cardiac Dysfunction H Qasim, M Rajaei, Y Xu, A Reyes-Alcaraz, HY Abdelnasser, MD Stewart, ... Circulation Research 134 (8), 1006-1022, 2024 | | 2024 |
| Corrigendum to “A novel inhibitor of MDM2 oncogene blocks metastasis of hepatocellular carcinoma and overcomes chemoresistance”[Genes Dis 694 (2019) 419–430] W Wang, B Hu, JJ Qin, J Cheng, X Li, M Rajaei, J Fan, XR Yang, R Zhang Genes & Diseases 7 (1), 160, 2020 | | 2020 |
| Targeted Mutagenesis Induced by CRISPR-Cas9 in Mouse Tyrosinase Gene M Rajaei, PA Overbeek Association of Clinical Scientists, 2018 | | 2018 |
| Comparison of the Epicentre Masterpure DNA Purification Kit and the QIAamp DNA Mini Kit for Isolation of Genomic DNA from Blood. B Hannigan, C Peng, M Rajaei, EA Welebob, W Ye, S Zalles, ... The Journal of the Association of Genetic Technologists 43 (3), 182, 2017 | | 2017 |
| CRISPR Insights Reveal a History of Recent Encounters with Group-A Streptococcus Phages in the Genomes of Group-C and Group-G Streptococci M Rajaei, EJ Thompson, PC Hu, A Kalia American Society for Microbiology, 2017 | | 2017 |
| Comparison of Whole Genome Sequencing and Conventional Molecular Techniques for Genotyping Bacterial Isolates Causing Bacteremia in Cancer Patients B Hannigan, C Peng, EA Welebob, M Rajaei, W Ye, S Zalles, V Varghese, ... The Association of Genetic Technologists, 2017 | | 2017 |
| Influence Of Smoking Habit On Age At Diagnosis Of Breast Cancer M Rajaei, S Omidvari, M Saadat Experimental and Applied Biomedical Research (EABR) 16 (3), 213-216, 2015 | | 2015 |
